RVPH
Reviva Pharmaceuticals Holdings
RVPHW7
$0.20arrow_drop_down1.63%-$0.00
Penny Stock
RVPH
RVPHW7
$0.20
arrow_drop_down1.63%Performance History
| Key Stats | |
|---|---|
| Open | $0.20 |
| Prev. Close | $0.20 |
| EPS | - |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $0.00 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.20 | 0.20 |
| 52 Week Range | 0.07 | 1.76 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | - |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Reviva Pharmaceuticals Holdings (RVPHW)
- Sector
- Industry
- CEO
- Headquarters
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on Reviva Pharmaceuticals Holdings
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Reviva Pharmaceuticals Holdings's (RVPHW) price per share?
The current price per share for Reviva Pharmaceuticals Holdings (RVPHW) is $0.2. The stock has seen a price change of -$0 recently, indicating a -1.64% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Reviva Pharmaceuticals Holdings (RVPHW)?
For Reviva Pharmaceuticals Holdings (RVPHW), the 52-week high is $1.76, which is 762.75% from the current price. The 52-week low is $0.08, the current price is 172% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Reviva Pharmaceuticals Holdings (RVPHW) a growth stock?
Reviva Pharmaceuticals Holdings (RVPHW) has shown an average price growth of -4.13% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Reviva Pharmaceuticals Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Reviva Pharmaceuticals Holdings (RVPHW) stock price performance year to date (YTD)?
As of the latest data, Reviva Pharmaceuticals Holdings (RVPHW) has a year-to-date price change of -86.92%. Over the past month, the stock has experienced a price change of 36%. Over the last three months, the change has been 153.1%. Over the past six months, the figure is -40%.
help
Is Reviva Pharmaceuticals Holdings (RVPHW) a profitable company?
Reviva Pharmaceuticals Holdings (RVPHW) has a net income of -$39.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$39.5M. Furthermore, the EBITDA is $0.
help
What is the market capitalization of Reviva Pharmaceuticals Holdings (RVPHW)?
Reviva Pharmaceuticals Holdings (RVPHW) has a market capitalization of $0. The average daily trading volume is 0.2, indicating the stock's liquidity and investor engagement.
News
SCHIZOPHRENIA
R&D
MARKET GROWTH
INNOVATIVE THERAPIES
PERSONALIZED MEDICINE
Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight
REVIVA PHARMACEUTICALS
UNDERWRITTEN OFFERING
COMMON STOCK
WARRANTS
RESEARCH AND DEVELOPMENT
PHASE 3 TRIAL
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules